Hallmark Capital Management Inc Crispr Therapeutics Ag Transaction History

Hallmark Capital Management Inc

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$60.67 - $89.12 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$38.62 - $72.18 $0 - $0	0 New	0 $0
Q3 2023 Nov 09, 2023	BUY	$45.39 - $59.0 $0 - $0	0 New	0 $0
Q2 2023 Jul 28, 2023	BUY	$43.47 - $67.77 $0 - $0	0 New	0 $0
Q1 2023 May 03, 2023	BUY	$41.0 - $56.12 $0 - $0	0 New	0 $0

Q4 2022 Feb 01, 2023	SELL	$39.19 - $65.67 $470 - $788	-12 Closed	0 $0
Q3 2022 Nov 09, 2022	BUY	$61.1 - $83.78 $733 - $1,005	12 New	12 $1,000

549

56.3M

2.91M

2.47M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.14B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Hallmark Capital Management Inc with notifications on news.